Back to Home

Generating Clinical, Scientific, And Financial Value In The Field Of Fertility Medicine

April 9, 2025

Share This Page
Facebook Logo
Twitter Logo
Linkedin Logo
Email Icon
View as PDF

Generating Clinical, Scientific, And Financial Value In The Field Of Fertility Medicine

June 9, 2025

Executive Summary

Fertility medicine is at the forefront of clinical innovation, offering patients an expanding array of treatment options.  Yet many clinics struggle to measure outcomes, track long-term success, or collaborate with peers in real-time.  RegenMed Circles changes that by giving fertility physicians the tools to collect structured, standardized, and compliant real-world data (RWD) from everyday clinical care.  The result?  Better insights, improved protocols, and enhanced outcomes — for every patient.

While revenue potential through data licensing is a key feature, the primary mission of RegenMed Circles is to create physician-led communities focused on accelerating treatment advancement and clinical excellence.  Through Circle participation, clinicians improve patient care while gaining access to rich benchmarking tools, peer collaboration, and professional growth opportunities.

Introduction

The fertility landscape is rapidly evolving.  From IVF and IUI to cryopreservation and emerging regenerative therapies like PRP, clinics are offering more options than ever before.  But despite technological and clinical advancements, most practices lack the infrastructure to collect meaningful, comparative outcome data across these treatments.

This limits a clinic’s ability to improve protocols, benchmark against peers, or contribute to broader research.  RegenMed Circles was built to close this gap — giving fertility providers a seamless way to track and analyze outcomes at scale.

The Opportunity: Closing the Outcomes Gap

Fertility care is outcome-driven, but few clinics have access to real-time, structured insights about their own performance — let alone how it compares to others.  Clinics often struggle to:

  • Standardize outcome tracking across providers and protocols
  • Analyze trends over time or across treatment types
  • Share knowledge or collaborate on clinical advancements

As patients become more outcome-aware and payers demand more data, the need for structured, real-world evidence is becoming essential — not optional.

We can build your Circle based on your preference of outcomes measurements through the creation of Scoring Formulas, like the ones pictured below, to help you identify treatment outcome trends.

Regenmed Circles: A Platform for Collaborative Care

RegenMed Circles are secure, collaborative networks that enable clinics to:

  • Collect and structure real-world treatment outcomes with zero workflow disruption
  • Compare anonymized results with national benchmarks
  • Collaborate with peers on protocols, research, and publications
  • Keep full ownership and control of their patient data

Each Circle focuses on a specific treatment domain or outcome type, examples include:

  • IVF cycle success and implantation rates
  • IUI outcomes and ovulation induction effectiveness
  • Egg and embryo freezing protocols
  • PRP for ovarian and endometrial support
  • Male fertility treatment response and trends

Physicians can join existing Circles or propose new ones based on their areas of interest.

Real-world evidence is becoming essential — not optional.

Improving Patient Outcomes Through Real-World Evidence

By collecting outcomes data in a structured, longitudinal format, clinics gain powerful tools to improve care:

  • Identify top-performing protocols and refine treatment plans
  • Enhance cycle prep strategies and optimize timing
  • Share de-identified insights across clinical teams
  • Track long-term patient success—not just short-term metrics

Circle members receive interactive dashboards, cohort-level reports, and access to collaborative datasets.  These tools empower fertility providers to continuously improve outcomes — without hiring new staff or disrupting care delivery.  See below for some examples of what the platform looks like and how it can be used to assess patient outcomes.

Patient Portal
Investigator Portal

Monetizing Your Real-World Data

In addition to improving care, RegenMed Circles create sustainable revenue through compliant, de-identified data licensing.  Clinics can:

  • License aggregate datasets to pharma, device, or digital health partners
  • Earn up to 85% of licensing revenue
  • Participate in studies that shape future treatment development

Revenue is just the beginning.  Circle participation supports scientific publications, conference presentations, and national recognition for clinical leadership.

Call to Action

Circles give fertility clinics a powerful way to elevate care and lead innovation.  Whether you're optimizing IVF protocols, testing regenerative approaches like PRP, or working to better understand male fertility — Circles make your outcomes work for you.

Join a growing network of physician-led innovators who are shaping the future of fertility care with real-world evidence.

Visit our Physicians-Owned Circles page or contact us to learn how to join or launch your own Circle.


Copyright © 2025 RegenMed, Inc.

Share This Page
Facebook Logo
Twitter Logo
Linkedin Logo
Email Icon

Generating Clinical, Scientific, And Financial Value In The Field Of Fertility Medicine

April 9, 2025

Executive Summary

Fertility medicine is at the forefront of clinical innovation, offering patients an expanding array of treatment options.  Yet many clinics struggle to measure outcomes, track long-term success, or collaborate with peers in real-time.  RegenMed Circles changes that by giving fertility physicians the tools to collect structured, standardized, and compliant real-world data (RWD) from everyday clinical care.  The result?  Better insights, improved protocols, and enhanced outcomes — for every patient.

While revenue potential through data licensing is a key feature, the primary mission of RegenMed Circles is to create physician-led communities focused on accelerating treatment advancement and clinical excellence.  Through Circle participation, clinicians improve patient care while gaining access to rich benchmarking tools, peer collaboration, and professional growth opportunities.

Introduction

The fertility landscape is rapidly evolving.  From IVF and IUI to cryopreservation and emerging regenerative therapies like PRP, clinics are offering more options than ever before.  But despite technological and clinical advancements, most practices lack the infrastructure to collect meaningful, comparative outcome data across these treatments.

This limits a clinic’s ability to improve protocols, benchmark against peers, or contribute to broader research.  RegenMed Circles was built to close this gap — giving fertility providers a seamless way to track and analyze outcomes at scale.

The Opportunity: Closing the Outcomes Gap

Fertility care is outcome-driven, but few clinics have access to real-time, structured insights about their own performance — let alone how it compares to others.  Clinics often struggle to:

  • Standardize outcome tracking across providers and protocols
  • Analyze trends over time or across treatment types
  • Share knowledge or collaborate on clinical advancements

As patients become more outcome-aware and payers demand more data, the need for structured, real-world evidence is becoming essential — not optional.

We can build your Circle based on your preference of outcomes measurements through the creation of Scoring Formulas, like the ones pictured below, to help you identify treatment outcome trends.

Regenmed Circles: A Platform for Collaborative Care

RegenMed Circles are secure, collaborative networks that enable clinics to:

  • Collect and structure real-world treatment outcomes with zero workflow disruption
  • Compare anonymized results with national benchmarks
  • Collaborate with peers on protocols, research, and publications
  • Keep full ownership and control of their patient data

Each Circle focuses on a specific treatment domain or outcome type, examples include:

  • IVF cycle success and implantation rates
  • IUI outcomes and ovulation induction effectiveness
  • Egg and embryo freezing protocols
  • PRP for ovarian and endometrial support
  • Male fertility treatment response and trends

Physicians can join existing Circles or propose new ones based on their areas of interest.

Real-world evidence is becoming essential — not optional.

Improving Patient Outcomes Through Real-World Evidence

By collecting outcomes data in a structured, longitudinal format, clinics gain powerful tools to improve care:

  • Identify top-performing protocols and refine treatment plans
  • Enhance cycle prep strategies and optimize timing
  • Share de-identified insights across clinical teams
  • Track long-term patient success—not just short-term metrics

Circle members receive interactive dashboards, cohort-level reports, and access to collaborative datasets.  These tools empower fertility providers to continuously improve outcomes — without hiring new staff or disrupting care delivery.  See below for some examples of what the platform looks like and how it can be used to assess patient outcomes.

Patient Portal
Investigator Portal

Monetizing Your Real-World Data

In addition to improving care, RegenMed Circles create sustainable revenue through compliant, de-identified data licensing.  Clinics can:

  • License aggregate datasets to pharma, device, or digital health partners
  • Earn up to 85% of licensing revenue
  • Participate in studies that shape future treatment development

Revenue is just the beginning.  Circle participation supports scientific publications, conference presentations, and national recognition for clinical leadership.

Call to Action

Circles give fertility clinics a powerful way to elevate care and lead innovation.  Whether you're optimizing IVF protocols, testing regenerative approaches like PRP, or working to better understand male fertility — Circles make your outcomes work for you.

Join a growing network of physician-led innovators who are shaping the future of fertility care with real-world evidence.

Visit our Physicians-Owned Circles page or contact us to learn how to join or launch your own Circle.


Copyright © 2025 RegenMed, Inc.

Share This Page
Facebook Logo
Twitter Logo
Linkedin Logo
Email Icon

Read The Latest

June 26, 2025

Invest in the Future: Webinar with Our CEO and Co-Founder

Discover the incredible growth potential of our company! Join our CEO and Co-Founder for insights into our $100B market opportunity, ongoing market traction, and future projections.

June 4, 2025

Advantages Of Circles Over "Big Data" RWE

Discover how Circles transform Big Data RWE by providing transparent, high-integrity insights directly from trusted sources. Say goodbye to fragmented, costly data and unlock meaningful, clinically relevant information while empowering physicians.

June 3, 2025

Peptides In Modern Medicine: Establishing Safety and Efficacy

Peptides are revolutionizing clinical diagnosis and treatment with their high selectivity and favorable side effect profiles. Here are some key insights:

RegenMed LLC Logo
Scroll Up Arrow

Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns.

Forward looking statements were included here that the Company believes to be accurate given the current information. They involve known and unknown risks, uncertainties and other important factors which if changed may affect the outcome(s).

DealMaker Securities LLC, a registered broker-dealer, and member of FINRA | SIPC, located at 4000 Eagle Point Corporate Drive, Suite 950, Birmingham, AL 35242., is the Intermediary for this offering and is not an affiliate of or connected with the Issuer.  Please check our background on FINRA's BrokerCheck.
DealMaker Securities LLC does not make investment recommendations.
DealMaker Securities LLC is NOT placing or selling these securities on behalf of the Issuer.
DealMaker Securities LLC is NOT soliciting this investment or making any recommendations by collecting, reviewing, and processing an Investor's documentation for this investment.
DealMaker Securities LLC conducts Anti-Money Laundering, Identity and Bad Actor Disqualification reviews of the Issuer, and confirms they are a registered business in good standing.
DealMaker Securities LLC is NOT vetting or approving the information provided by the Issuer or the Issuer itself.

Contact information is provided for Investors to make inquiries and requests to DealMaker Securities LLC regarding Regulation CF in general, or the status of such investor’s submitted documentation, specifically. DealMaker Securities LLC may direct Investors to specific sections of the Offering Circular to locate information or answers to their inquiry but does not opine or provide guidance on issuer related matters.

Copyright © 2025. RegenMed, Inc. All rights reserved.